494
Participants
Start Date
November 30, 2009
Primary Completion Date
May 31, 2012
BI 10773 placebo
BI 10773 placebo
BI 10773 low dose
BI 10773 low dose
BI 10773 high dose
BI 10773 high dose
BI 10773 placebo
BI 10773 placebo
1245.33.01014 Boehringer Ingelheim Investigational Site, Birmingham
1245.33.01047 Boehringer Ingelheim Investigational Site, Phoenix
1245.33.01060 Boehringer Ingelheim Investigational Site, Fresno
1245.33.01013 Boehringer Ingelheim Investigational Site, Los Angeles
1245.33.01008 Boehringer Ingelheim Investigational Site, Los Gatos
1245.33.01019 Boehringer Ingelheim Investigational Site, National City
1245.33.01055 Boehringer Ingelheim Investigational Site, Paramount
1245.33.01012 Boehringer Ingelheim Investigational Site, Santa Ana
1245.33.01054 Boehringer Ingelheim Investigational Site, Denver
1245.33.01046 Boehringer Ingelheim Investigational Site, Bradednton
1245.33.01050 Boehringer Ingelheim Investigational Site, Brooksville
1245.33.01059 Boehringer Ingelheim Investigational Site, Chiefland
1245.33.01028 Boehringer Ingelheim Investigational Site, Clearwater
1245.33.01029 Boehringer Ingelheim Investigational Site, Fleming Island
1245.33.01048 Boehringer Ingelheim Investigational Site, Hollywood
1245.33.01033 Boehringer Ingelheim Investigational Site, New Port Richey
1245.33.01027 Boehringer Ingelheim Investigational Site, Atlanta
1245.33.01040 Boehringer Ingelheim Investigational Site, Decatur
1245.33.01062 Boehringer Ingelheim Investigational Site, Lawrenceville
1245.33.01020 Boehringer Ingelheim Investigational Site, Chicago
1245.33.01044 Boehringer Ingelheim Investigational Site, Chicago
1245.33.01024 Boehringer Ingelheim Investigational Site, Des Moines
1245.33.01022 Boehringer Ingelheim Investigational Site, Saint Louis
1245.33.01056 Boehringer Ingelheim Investigational Site, Olive Branch
1245.33.01032 Boehringer Ingelheim Investigational Site, Kansas City
1245.33.01017 Boehringer Ingelheim Investigational Site, Omaha
1245.33.01043 Boehringer Ingelheim Investigational Site, Las Vegas
1245.33.01051 Boehringer Ingelheim Investigational Site, New Hartford
1245.33.01007 Boehringer Ingelheim Investigational Site, Greensboro
1245.33.01003 Boehringer Ingelheim Investigational Site, Jacksonville
1245.33.01016 Boehringer Ingelheim Investigational Site, Salisbury
1245.33.01005 Boehringer Ingelheim Investigational Site, Statesville
1245.33.01038 Boehringer Ingelheim Investigational Site, Wilmington
1245.33.01026 Boehringer Ingelheim Investigational Site, Winston-Salem
1245.33.01025 Boehringer Ingelheim Investigational Site, Cincinnati
1245.33.01001 Boehringer Ingelheim Investigational Site, Columbus
1245.33.01031 Boehringer Ingelheim Investigational Site, Tulsa
1245.33.01045 Boehringer Ingelheim Investigational Site, Eugene
1245.33.01018 Boehringer Ingelheim Investigational Site, Altoona
1245.33.01041 Boehringer Ingelheim Investigational Site, Carlisle
1245.33.01042 Boehringer Ingelheim Investigational Site, Landsdale
1245.33.01004 Boehringer Ingelheim Investigational Site, Greer
1245.33.01036 Boehringer Ingelheim Investigational Site, Mt. Pleasant
1245.33.01035 Boehringer Ingelheim Investigational Site, Seneca
1245.33.01058 Boehringer Ingelheim Investigational Site, Kingsport
1245.33.01037 Boehringer Ingelheim Investigational Site, Memphis
1245.33.01023 Boehringer Ingelheim Investigational Site, Dallas
1245.33.01030 Boehringer Ingelheim Investigational Site, Dallas
1245.33.01006 Boehringer Ingelheim Investigational Site, Houston
1245.33.01011 Boehringer Ingelheim Investigational Site, Houston
1245.33.01002 Boehringer Ingelheim Investigational Site, Sugar Land
1245.33.01049 Boehringer Ingelheim Investigational Site, Salt Lake City
1245.33.01015 Boehringer Ingelheim Investigational Site, Norfolk
1245.33.01009 Boehringer Ingelheim Investigational Site, Richmond
1245.33.01010 Boehringer Ingelheim Investigational Site, Federal Way
1245.33.01061 Boehringer Ingelheim Investigational Site, Milwaukee
1245.33.45006 Boehringer Ingelheim Investigational Site, Aalborg
1245.33.45001 Boehringer Ingelheim Investigational Site, Aarhus C
1245.33.45011 Boehringer Ingelheim Investigational Site, Aarhus C
1245.33.45013 Boehringer Ingelheim Investigational Site, Aarhus C
1245.33.45004 Boehringer Ingelheim Investigational Site, Gentofte Municipality
1245.33.45008 Boehringer Ingelheim Investigational Site, Hillerød
1245.33.45002 Boehringer Ingelheim Investigational Site, Hvidovre
1245.33.45003 Boehringer Ingelheim Investigational Site, København NV
1245.33.3301A Boehringer Ingelheim Investigational Site, Bondy
1245.33.3302A Boehringer Ingelheim Investigational Site, Corbeil-Essonnes
1245.33.3305A Boehringer Ingelheim Investigational Site, La Rochelle
1245.33.3306A Boehringer Ingelheim Investigational Site, Marseille
1245.33.3308A Boehringer Ingelheim Investigational Site, Montbrison
1245.33.3309A Boehringer Ingelheim Investigational Site, Nanterre
1245.33.3310A Boehringer Ingelheim Investigational Site, Nantes
1245.33.3304A Boehringer Ingelheim Investigational Site, Narbonne
1245.33.3303A Boehringer Ingelheim Investigational Site, Saint-Mandé
1245.33.35302 Boehringer Ingelheim Investigational Site, Dublin
1245.33.35303 Boehringer Ingelheim Investigational Site, Dublin
1245.33.35304 Boehringer Ingelheim Investigational Site, Dublin
1245.33.35104 Boehringer Ingelheim Investigational Site, Aveiro
1245.33.35101 Boehringer Ingelheim Investigational Site, Coimbra
1245.33.35102 Boehringer Ingelheim Investigational Site, Lisbon
1245.33.35106 Boehringer Ingelheim Investigational Site, Lisbon
1245.33.35107 Boehringer Ingelheim Investigational Site, Lisbon
1245.33.82008 Boehringer Ingelheim Investigational Site, Daejeon
1245.33.82007 Boehringer Ingelheim Investigational Site, Gwangju
1245.33.82001 Boehringer Ingelheim Investigational Site, Seoul
1245.33.82003 Boehringer Ingelheim Investigational Site, Seoul
1245.33.82004 Boehringer Ingelheim Investigational Site, Seoul
1245.33.82005 Boehringer Ingelheim Investigational Site, Seoul
1245.33.82006 Boehringer Ingelheim Investigational Site, Wŏnju
1245.33.82002 Boehringer Ingelheim Investigational Site, Yangsan
1245.33.44001 Boehringer Ingelheim Investigational Site, Bath
1245.33.44003 Boehringer Ingelheim Investigational Site, Birmingham
1245.33.44006 Boehringer Ingelheim Investigational Site, Blackburn
1245.33.44005 Boehringer Ingelheim Investigational Site, Dorking
1245.33.44009 Boehringer Ingelheim Investigational Site, Headington
1245.33.44008 Boehringer Ingelheim Investigational Site, Leicester
1245.33.44004 Boehringer Ingelheim Investigational Site, Liverpool
1245.33.44007 Boehringer Ingelheim Investigational Site, Wembley
1245.33.44002 Boehringer Ingelheim Investigational Site, Whitstable
1245.33.44010 Boehringer Ingelheim Investigational Site, Wymondham
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Boehringer Ingelheim
INDUSTRY